Role of nurses in supporting proactive deprescribing.


Journal

Nursing standard (Royal College of Nursing (Great Britain) : 1987)
ISSN: 2047-9018
Titre abrégé: Nurs Stand
Pays: England
ID NLM: 9012906

Informations de publication

Date de publication:
22 02 2019
Historique:
accepted: 19 07 2018
entrez: 31 8 2019
pubmed: 31 8 2019
medline: 1 7 2020
Statut: ppublish

Résumé

Deprescribing is the term used to describe the discontinuation of medicines. It can be either 'reactive', for example in response to an adverse event or therapeutic failure, or 'proactive', when the prescriber and patient decide to discontinue the medicine because its future benefits no longer outweigh its potential for harm. At present, there is a limited amount of proactive deprescribing activity in primary and secondary care. This article provides the rationale for increasing proactive deprescribing activity, lists the medicines this relates to, identifies the barriers and enablers to its implementation, and describes the potential role of the nurse in this process.

Identifiants

pubmed: 31468926
doi: 10.7748/ns.2019.e11249
pii: e11249
doi:

Substances chimiques

Cholinergic Antagonists 0
Proton Pump Inhibitors 0
Benzodiazepines 12794-10-4

Types de publication

Journal Article Review

Langues

eng

Pagination

44-50

Informations de copyright

© 2019 RCN Publishing Company Ltd. All rights reserved. Not to be copied, transmitted or recorded in any way, in whole or part, without prior permission of the publishers.

Déclaration de conflit d'intérêts

None declared

Auteurs

David John Wright (DJ)

School of Pharmacy, University of East Anglia, Norwich, England.

Sion Scott (S)

School of Pharmacy, University of East Anglia, Norwich, England.

Jackie Buck (J)

School of Health Sciences, University of East Anglia, Norwich, England.

Debi Bhattacharya (D)

School of Pharmacy, University of East Anglia, Norwich, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH